Literature DB >> 4902915

Toxoplasmosis in patients receiving immunosuppressive therapy.

S N Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4902915

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Toxoplasma encephalitis complicating Hodgkin's disease.

Authors:  J D Whiteside; R H Begent
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

2.  Immunosuppressive agents in intracellular infection: besnoitiosis in hamsters.

Authors:  H R Wilson; J K Frenkel
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

3.  Surgical management of complications of steroid therapy.

Authors:  A G Diethelm
Journal:  Ann Surg       Date:  1977-03       Impact factor: 12.969

Review 4.  Toxoplasmosis in the adult.

Authors:  J S Remington
Journal:  Bull N Y Acad Med       Date:  1974-02

5.  Effect of antithymocyte serum on experimental toxoplasmosis in mice.

Authors:  O Strannegård; E Lycke
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

Review 6.  Understanding mechanisms and the role of differentiation in pathogenesis of Toxoplasma gondii: a review.

Authors:  William J Sullivan; Aaron T Smith; Bradley R Joyce
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

Review 7.  Ocular toxoplasmosis in the immunocompromised host.

Authors:  G N Holland
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

8.  Immune competence in a patient with Hodgkin's disease and relapsing toxoplasmosis.

Authors:  J K Frenkel; M Amare; W Larsen
Journal:  Infection       Date:  1978       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.